Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Perkus

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Science (New York, N.Y.)|October 16, 1970
Wasting wasteM E Perkus, M Lieb
Journal of Virology|October 1, 1985
Mapping the genes in the terminal redundancy of bacteriophage SPO1 with restriction endonucleasesM E Perkus, D A Shub
Antiviral Research|January 1, 1985
Live recombinant vaccines using genetically engineered vaccinia virusE Paoletti, M E Perkus, A Piccini
Journal of Virology|September 1, 1989
Cloning and expression of foreign genes in vaccinia virus, using a host range selection systemM E Perkus, K Limbach, E Paoletti
Methods in Enzymology|January 1, 1987
Vaccinia virus as an expression vectorA Piccini, M E Perkus, E Paoletti
Journal of Leukocyte Biology|July 1, 1995
Poxvirus-based vaccine candidates for cancer, AIDS, and other infectious diseasesM E Perkus, J Tartaglia, E Paoletti
Virology|July 30, 1986
Insertion and deletion mutants of vaccinia virusM E Perkus, D Panicali, S Mercer, et al.
Science (New York, N.Y.)|September 6, 1985
Recombinant vaccinia virus: immunization against multiple pathogensM E Perkus, A Piccini, B R Lipinskas, et al.
The Journal of Infectious Diseases|April 1, 1989
Regulation of expression of herpes simplex virus (HSV) glycoprotein D in vaccinia recombinants affects their ability to protect from cutaneous HSV-2 diseaseM Wachsman, L Aurelian, C C Smith, et al.
The Journal of General Virology|September 1, 1989
Antigen-presenting capacity of epidermal cells infected with vaccinia virus recombinants containing the herpes simplex virus glycoprotein D, and protective immunityM Wachsman, J H Luo, L Aurelian, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Science (New York, N.Y.)|October 16, 1970
Wasting wasteM E Perkus, M Lieb
Journal of Virology|October 1, 1985
Mapping the genes in the terminal redundancy of bacteriophage SPO1 with restriction endonucleasesM E Perkus, D A Shub
Antiviral Research|January 1, 1985
Live recombinant vaccines using genetically engineered vaccinia virusE Paoletti, M E Perkus, A Piccini
Journal of Virology|September 1, 1989
Cloning and expression of foreign genes in vaccinia virus, using a host range selection systemM E Perkus, K Limbach, E Paoletti
Methods in Enzymology|January 1, 1987
Vaccinia virus as an expression vectorA Piccini, M E Perkus, E Paoletti
Journal of Leukocyte Biology|July 1, 1995
Poxvirus-based vaccine candidates for cancer, AIDS, and other infectious diseasesM E Perkus, J Tartaglia, E Paoletti
Virology|July 30, 1986
Insertion and deletion mutants of vaccinia virusM E Perkus, D Panicali, S Mercer, et al.
Science (New York, N.Y.)|September 6, 1985
Recombinant vaccinia virus: immunization against multiple pathogensM E Perkus, A Piccini, B R Lipinskas, et al.
The Journal of Infectious Diseases|April 1, 1989
Regulation of expression of herpes simplex virus (HSV) glycoprotein D in vaccinia recombinants affects their ability to protect from cutaneous HSV-2 diseaseM Wachsman, L Aurelian, C C Smith, et al.
The Journal of General Virology|September 1, 1989
Antigen-presenting capacity of epidermal cells infected with vaccinia virus recombinants containing the herpes simplex virus glycoprotein D, and protective immunityM Wachsman, J H Luo, L Aurelian, et al.
Pageof 3